Amid the Biotech Madness, I Spotted an Opening in a Promising Small-Cap

Avatar photo James "Rev Shark" DePorre on October 12, 2026

Hedge funds dumped genomics plays like this one last week … but it was just as it announced a new AstraZeneca-linked deal.